The story of the blue pill offers a complex case study for investors eyeing the pharmaceutical sector. While early sales were remarkable, current patent expiration and the rise of generic versions have considerably https://craigwuwl922859.blog-gold.com/58202790/sildenafil-and-big-pharma-a-dangerous-investment